Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,176 JPY | +1.98% |
|
+3.26% | +3.01% |
06-24 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
06-24 | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.01% | 40.23B | |
+52.70% | 801B | |
+41.58% | 631B | |
-4.86% | 359B | |
+21.96% | 337B | |
+11.47% | 305B | |
+17.72% | 245B | |
+4.46% | 231B | |
+13.13% | 219B | |
+10.46% | 171B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 02